TABLE 2.

Changes in nucleoside analog treatments

Time	No. of patients receivinga:
	Abacavir	Didanosine	Lamivudine	Stavudine	Zalcitabine	Zidovudine
Inclusion	3	4	5	2	1	1
Wk 2 to 6	7	4	7	1	2	4
Introduced at wk 2	5	2	5	1	2	4

^aThe patient excluded from the study received lamivudine.